Correlation Between Agios Pharm and XTL Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on Agios Pharm and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and XTL Biopharmaceutica.
Diversification Opportunities for Agios Pharm and XTL Biopharmaceutica
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agios and XTL is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Agios Pharm i.e., Agios Pharm and XTL Biopharmaceutica go up and down completely randomly.
Pair Corralation between Agios Pharm and XTL Biopharmaceutica
Given the investment horizon of 90 days Agios Pharm is expected to generate 0.72 times more return on investment than XTL Biopharmaceutica. However, Agios Pharm is 1.4 times less risky than XTL Biopharmaceutica. It trades about 0.38 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about -0.18 per unit of risk. If you would invest 4,487 in Agios Pharm on September 2, 2024 and sell it today you would earn a total of 1,452 from holding Agios Pharm or generate 32.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. XTL Biopharmaceuticals Ltd
Performance |
| Timeline |
| Agios Pharm |
| XTL Biopharmaceuticals |
Agios Pharm and XTL Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and XTL Biopharmaceutica
The main advantage of trading using opposite Agios Pharm and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| XTL Biopharmaceutica vs. Tff Pharmaceuticals | XTL Biopharmaceutica vs. Eliem Therapeutics | XTL Biopharmaceutica vs. Inhibrx | XTL Biopharmaceutica vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |